Characterization of mRNA therapeutics
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Therapeutic messenger RNAs (mRNAs) have emerged as powerful tools in the treatment of complex diseases, especially for conditions that lack efficacious treatment. The successful application of this modality can be attributed to its ability to encode entire proteins. While the large nature of these molecules has supported their success as therapeutics, its extended size creates several analytical challenges. To further support therapeutic mRNA development and its deployment in clinical trials, appropriate methods to support their characterization must be developed. In this review, we describe current analytical methods that have been used in the characterization of RNA quality, identity, and integrity. Advantages and limitations from several analytical techniques ranging from gel electrophoresis to liquid chromatography–mass spectrometry and from shotgun sequencing to intact mass measurements are discussed. We comprehensively describe the application of analytical methods in the measurements of capping efficiency, poly A tail analysis, as well as their applicability in stability studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although it is a sensitive and high-resolution method, the analysis of long mRNA can be challenging due to multiply charged states and associated spectral complexity.21,46”
From Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses (2024) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
Self-citationKarikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
Kozak, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90418-9 · Cited by 1,182
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898
Codon optimality, bias and usage in translation and mRNA decay
Hanson, G., & Coller, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.91 · Cited by 825
Taylor, S. C., Laperriere, G., & Germain, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-02217-x · Cited by 638
Research works printed but not linked: 117
- 10.1038/mt.2012.29 · DOI · Paper page
- 10.1093/nar/29.2.e7 · DOI
- 10.7554/eLife.76562 · DOI
- 10.1002/(SICI)1096-9888(199611)31:11<1277::AID-JMS418>3.0.CO;2-F · doi:10.1002/(sici)1096-9888(199611)31:11<1277::aid-jms418>3.0.co;2-f
- 10.4155/bio.14.94 · DOI
- 10.1007/s13361-016-1500-3 · doi:10.1007/s13361-016-1500-3
- 10.1038/s41598-018-27570-3 · DOI
- 10.1021/ac970163e · DOI · Paper page
- 10.1007/s00216-017-0840-6 · DOI
- Bilska A, 2022, Measuring the tail: Methods for poly (A) tail profiling, e1737
- 10.1016/j.jphotobiol.2013.09.010 · DOI
- Brophy P, 2022, Characterization of intact mRNA using IP‐RP‐TOF‐MS, SEC MALS and CDMS, ASMS Conference, TP405
- 10.1038/nbt.3622 · DOI
- 10.1021/ja00096a046 · DOI · Paper page
- 10.1016/j.chroma.2013.03.003 · doi:10.1016/j.chroma.2013.03.003
- 10.1021/ac00103a004 · DOI
- 10.1093/nar/24.11.2183 · doi:10.1093/nar/24.11.2183
- 10.1016/j.chroma.2016.02.057 · doi:10.1016/j.chroma.2016.02.057
- 10.1021/acs.analchem.2c03030 · DOI
- Currie J, 2021, Stability indicating ion‐pair reversed‐phase liquid chromatography method for modified mRNA, ChemRxiv
- 10.1038/s41467-022-30057-5 · DOI
- 10.1093/nar/gkac414 · DOI
- 10.1016/j.chroma.2018.05.048 · DOI
- 10.1016/j.chroma.2021.462283 · DOI
- 10.1002/mas.21798 · DOI
- 10.1016/j.chroma.2022.462860 · DOI
- 10.1002/bmc.4088 · DOI
- 10.1021/ac00179a722 · doi:10.1021/ac00179a722
- 10.1021/acs.analchem.1c05466 · doi:10.1021/acs.analchem.1c05466
- 10.1016/j.jcoa.2022.100031 · DOI
- 10.1021/acscentsci.1c00788 · DOI
- Foreman D, 2022, Negative mode charge detection mass spectrometry: mass determination of intact mRNA, ASMS Conference, 8, 50
- 10.1002/rcm.1290091513 · DOI · Paper page
- 10.1186/s13059-020-02241-7 · DOI · Paper page
- 10.1038/nmeth.4577 · DOI · Paper page
- 10.1016/S0021-9673(99)01178-4 · doi:10.1016/s0021-9673(99)01178-4
- 10.1016/j.omtm.2022.03.009 · DOI · Paper page
- 10.1016/j.jpba.2021.114439 · doi:10.1016/j.jpba.2021.114439
- 10.1021/ac990160x · doi:10.1021/ac990160x
- 10.1186/1471-2229-13-119 · DOI
- 10.1186/s13059-021-02557-y · DOI
- 10.1021/ac00099a015 · doi:10.1021/ac00099a015
- 10.1093/nar/gni054 · DOI · Paper page
- 10.1038/s41592-022-01633-w · DOI · Paper page
- 10.1261/rna.031898.111 · DOI · Paper page
- 10.1021/acs.chemrev.1c00377 · DOI
- 10.3390/vaccines9090965 · DOI
- 10.1021/acs.analchem.9b01664 · DOI
- 10.1128/MCB.26.6.2419-2429.2006 · DOI
- 10.1126/science.1225829 · DOI · Paper page
- 10.1038/s41598-018-37642-z · DOI
- 10.1038/nature04734 · DOI · Paper page
- 10.1002/jms.4465 · DOI
- 10.1016/j.omtn.2019.07.006 · DOI
- 10.1016/j.jchromb.2022.123168 · doi:10.1016/j.jchromb.2022.123168
- 10.1111/dgd.12608 · DOI · Paper page
- 10.1016/0092-8674(78)90150-2 · DOI
- 10.1021/acs.analchem.2c04114 · DOI
- 10.1038/s41467-021-27393-3 · DOI · Paper page
- Liau B, 2021, Rapid Analysis of mRNA 5′ capping with high‐resolution LC/MS
- 10.1002/(SICI)1098-2787(1996)15:5<297::AID-MAS2>3.0.CO;2-D · DOI
- 10.1002/wrna.1367 · DOI
- 10.1016/j.ymeth.2018.10.012 · DOI
- 10.1016/j.chroma.2020.460875 · DOI
- 10.1261/rna.5264804 · DOI · Paper page
- 10.1021/ja00078a054 · doi:10.1021/ja00078a054
- 10.1016/1044-0305(92)85019-G · DOI · Paper page
- 10.4161/rna.27992 · DOI
- Morreel K, 2022, Diving into the structural details of in vitro transcribed mRNA using liquid chromatography–mass spectrometry‐based oligonucleotide profiling. LCGC, Europe, 35, 220
- 10.1016/j.aca.2021.338987 · DOI
- 10.1093/nar/gkp099 · DOI
- 10.32607/20758251-2011-3-2-22-33 · DOI
- 10.1038/s41592-022-01513-3 · DOI
- 10.1021/ac960270t · DOI · Paper page
- 10.1021/ja00035a012 · DOI · Paper page
- 10.1007/s13361-012-0529-1 · doi:10.1007/s13361-012-0529-1
- 10.1021/ac015595a · doi:10.1021/ac015595a
- 10.1002/rcm.8927 · DOI
- 10.1038/s41467-021-26926-0 · DOI · Paper page
- 10.7554/eLife.49658 · DOI · Paper page
- 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.0.CO;2-W · DOI
- 10.1002/rcm.338 · doi:10.1002/rcm.338
- 10.1038/s41392-022-01007-w · DOI · Paper page
- 10.1016/j.cancergen.2020.02.007 · DOI
- 10.1002/jms.3207 · DOI
- 10.1002/elps.202100272 · DOI
- 10.1093/nar/gkw551 · DOI · Paper page
- 10.1101/pdb.prot5445 · doi:10.1101/pdb.prot5445
- 10.1002/elps.11501301102 · DOI
- 10.1261/rna.049429.114 · DOI
- 10.1016/S1044-0305(01)00354-3 · doi:10.1016/s1044-0305(01)00354-3
- 10.1006/meth.1998.0705 · DOI · Paper page
- 10.1073/pnas.74.12.5463 · DOI · Paper page
- Schneeberger E, 2021, Expanding the Horizon: LC‐MS approaches for intact mass spectrometry of pharmaceutical mRNA up to 2000‐nt long, ASMS Conference, 2, 30
- 10.1002/elps.1150170917 · DOI
- 10.1002/cpmb.59 · DOI · Paper page
- SmithAM JainM MulroneyL GaraldeDR andAkesonM.Reading canonical and modified nucleotides in 16S ribosomal RNA using nanopore direct RNA sequencing. bioRxiv.2017:132274. · DOI
- 10.1021/acsomega.2c00185 · DOI
- 10.1002/elps.200800457 · DOI
- 10.1002/mas.21641 · DOI
- TavakoliS NabizadehmashhadtoroghiM MakhamrehA GamperH McCormickCA RezapourNK HouY‐M WanunuM andRouhanifardSH.Semi‐quantitative detection of pseudouridine modifications and type I/II hypermodifications in human mRNAs using direct and long‐read sequencing. bioRxiv.2022:2021.2011.2003.467190.
- Technologies A, 2020, Comparison of RIN and RQN for the Agilent 2100 bioanalyzer and fragment analyzer systems, Application Note, 5994
- 10.1002/1522-2683(200107)22:12<2442::AID-ELPS2442>3.0.CO;2-9 · doi:10.1002/1522-2683(200107)22:12<2442::aid-elps2442>3.0.co;2-9
- 10.1016/j.yexcr.2014.01.008 · DOI · Paper page
- 10.1021/acs.analchem.2c00765 · DOI
- 10.1101/gr.247064.118 · DOI · Paper page
- Wang P, 2022, SEC‐MALS Method for Characterizing mRNA Biophysical Attributes
- 10.1016/j.chroma.2022.462839 · DOI
- 10.1038/s41467-020-14665-7 · DOI
- 10.2144/97223st01 · DOI · Paper page
- 10.1093/nar/gkac632 · DOI
- 10.3389/fmicb.2019.00260 · DOI
- 10.1261/rna.073858.119 · DOI · Paper page
- 10.1016/j.chroma.2013.09.021 · doi:10.1016/j.chroma.2013.09.021
- 10.1016/0076-6879(89)80090-4 · DOI
- 10.1021/acs.analchem.7b01780 · DOI
- 10.3390/ijms23052736 · DOI · Paper page
Cited by
Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses
Camperi, J., Roper, B., Freund, E., Leylek, R., Nissenbaum, A., Galan, C., Caothien, R., Hu, Z., Ko, P., Lee, A., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04162 · Cited by 22
Metadata
- Authors
- Guimaraes, G. J., Kim, J., & Bartlett, M. G.
- Venue
- Mass Spectrometry Reviews
- Publisher
- Wiley
- Published
- 2023-07-04
- Volume
- 43
- Issue
- 5
- Pages
- 1066-1090
- ISSN
- 0277-7037
- 1098-2787
- Cited by
- 44
- References
- 28
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of mRNA therapeutics. https://app.cochat.ai/papers/10.1002/mas.21856
- The paper
- Guimaraes, G. J., Kim, J., & Bartlett, M. G. (2024). Characterization of mRNA therapeutics. Mass Spectrometry Reviews. https://doi.org/10.1002/mas.21856
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.